SAN JOSE, Calif. --(BUSINESS WIRE)--Nov. 29, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will participate in a virtual panel

SAN JOSE, Calif. --(BUSINESS WIRE)--Nov. 9, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two

Reiterates Updated 2023 Revenue Guidance of Approximately $130 Million SAN JOSE, Calif. --(BUSINESS WIRE)--Nov. 7, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of

Studies reinforce the influence of new technology on effective, efficient kidney care SAN JOSE, Calif. --(BUSINESS WIRE)--Nov. 1, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, today

SAN JOSE, Calif. --(BUSINESS WIRE)--Oct. 30, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that it will release financial results for the third quarter of

Conference Call Scheduled for 4:30 p.m. ET SAN JOSE, Calif. --(BUSINESS WIRE)--Oct. 12, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), today announced preliminary financial results for the third quarter ended Sept. 30, 2023 , and provided updated financial guidance for 2023.

SAN JOSE, Calif. --(BUSINESS WIRE)--Aug. 29, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at

Sequential Revenue Growth of 8%, Ninth Consecutive Quarter of Gross Margin Expansion Announces Shipment Pause of TabloCart with Prefiltration Pending 510(k) Clearance Reiterates 2023 Revenue Range of $144 Million to $150 Million SAN JOSE, Calif. --(BUSINESS WIRE)--Aug.

SAN JOSE, Calif. --(BUSINESS WIRE)--Jul. 13, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that it will release financial results for the second quarter of

SAN JOSE, Calif. --(BUSINESS WIRE)--Jun. 6, 2023-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at